Kewaunee Scientific Corporation Appoints Jorge Santos as Vice President of International Sales, Laboratory Products Group
Rhea-AI Summary
Kewaunee Scientific (NASDAQ: KEQU) appointed Jorge Santos as Vice President, International Sales, Laboratory Products Group, effective April 14, 2026. Santos, based in Madrid, brings over 20 years of international commercial leadership across 25+ countries to support global expansion following the NuAire acquisition. The move targets deeper penetration in Europe, Middle East, Asia, and continued strength in India under existing leadership.
The company said Santos will report to CEO Thomas D. Hull III and work alongside regional leaders to leverage Kewaunee and NuAire portfolios for integrated laboratory solutions worldwide.
Positive
- Experienced hire: Jorge Santos brings 20+ years of international commercial leadership
- Global reach: Santos has built dealer networks across 25+ countries, aiding expansion
- Acquisition synergy: Role intended to accelerate integration of Kewaunee and NuAire product portfolios
Negative
- Execution risk: Realizing benefits depends on successfully integrating NuAire into global operations
- Market concentration: India remains largest international market, creating geographic dependence risks
- International challenges: Expansion faces supply, regulatory, and currency risks noted in forward-looking statements
News Market Reaction – KEQU
In the Apr 15 session, KEQU gained 1.05%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Mar 11 | Earnings release | Negative | -13.1% | Q3 2026 results showed higher sales but weaker net earnings and EPS. |
| Mar 03 | Conference presence | Positive | -1.3% | Announcement of attendance at analytica 2026 with integrated lab solutions. |
| Feb 25 | Earnings date notice | Neutral | -2.1% | Scheduling update for Q3 2026 results release after market close. |
| Jan 15 | Order win | Positive | +6.3% | Unusual Machines announced a $2.1M NDAA-compliant drone component order. |
| Dec 10 | Earnings release | Negative | -4.3% | Q2 2026 results with strong revenue growth but lower pre-tax earnings. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent KEQU news, including earnings and corporate updates, has often been followed by negative price reactions, even when operating metrics like sales or international growth improved.
Over the past several months, Kewaunee reported mixed earnings, with third‑quarter fiscal 2026 net sales of $69.399M but lower net earnings and a -13.08% next‑day move. Earlier, second‑quarter fiscal 2026 showed strong sales growth to $70.096M yet the stock fell 4.35%. Non-earnings updates such as conference attendance and earnings date notices on 03/03/2026 and 02/25/2026 also saw modest declines. Against this backdrop, the leadership appointment and international focus fit an ongoing narrative of integration and global expansion alongside volatile share responses.
Key Terms
biological safety cabinets medical
co2 incubators medical
forward-looking statements regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.
"Jorge's appointment marks a significant step forward in Kewaunee's growth strategy outside of the North American market," said Thomas D. Hull III, President & Chief Executive Officer of Kewaunee Scientific Corporation. "Historically, Kewaunee's focus outside of the North American market has been primarily within the Indian,
"Jorge is an industry veteran based in
"Kewaunee is uniquely equipped to bring a more complete, integrated laboratory solution to the global market," Hull added. "With Jorge's experience and established relationships across
As Kewaunee's presence expands globally, the Company remains firmly committed to the leadership and focus that have long driven success in its core markets. Domestic sales operations for both Kewaunee and Nu Aire will continue under the leadership of Ryan Noble, Vice President of Sales & Market Development, whose driven and customer-focused approach has been instrumental in maintaining consistent execution, strong engagement, and healthy growth across the Company's key markets. Noble's deep regional expertise and close relationships with Kewaunee's customers and partners remain central to the Company's commercial success.
As the Indian economy continues to represent a robust, long term growth opportunity for the Company, B. Sathyamurthy (Sathya), President of Kewaunee International Group, will continue driving Kewaunee International Group operations. Sathya has spent more than 25 years building and scaling Kewaunee's International Group, helping establish
Hull further emphasized that the Company's global expansion will continue to be built on strong, market-tailored leadership and focused investment. "We see an exciting opportunity ahead for Kewaunee on the global stage. I believe we have the strongest commercial leadership in the industry, and the addition of Jorge's experience and leadership further strengthens our organization and will help us deepen our presence in the markets where the demand for advanced laboratory environments continues to accelerate."
About Kewaunee Scientific
Founded in 1906, Kewaunee Scientific Corporation is a recognized global leader in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products. The Company's products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks. The Company's corporate headquarters are located in
Kewaunee Scientific's newly acquired subsidiary, Nu Aire, Inc. (NuAire), is a leading manufacturer of biological safety cabinets, CO2 incubators, ultralow freezers, and other essential laboratory products that complement the Kewaunee Scientific portfolio. Founded in 1971, NuAire's headquarters and manufacturing facilities are located in
Learn more at the companies' websites, located at http://www.kewaunee.com and http://www.nuaire.com/.
This press release contains statements that the Company believes to be "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact included in this press release, including statements regarding the Company's future financial condition, results of operations, business operations and business prospects, are forward-looking statements. Words such as "anticipate," "estimate," "expect," "project," "intend," "plan," "predict," "believe" and similar words, expressions and variations of these words and expressions are intended to identify forward-looking statements. Such forward-looking statements are subject to known and unknown risks, uncertainties, assumptions, and other important factors that could significantly impact results or achievements expressed or implied by such forward-looking statements. Such factors, risks, uncertainties and assumptions include, but are not limited to: our ability to realize the benefits anticipated as a result of the NuAire acquisition; competitive and general economic conditions, including disruptions from government mandates, both domestically and internationally, as well as supplier constraints and other supply disruptions; changes in customer demands; technological changes in our operations or in our industry; dependence on customers' required delivery schedules; risks related to fluctuations in the Company's operating results from quarter to quarter; risks related to international operations, including foreign currency fluctuations; changes in the legal and regulatory environment; changes in raw materials and commodity costs; acts of terrorism, war, governmental action, and natural disasters and other Force Majeure events. The cautionary statements made pursuant to the Reform Act herein and elsewhere by us should not be construed as exhaustive. We cannot always predict what factors would cause actual results to differ materially from those indicated by the forward-looking statements. Over time, our actual results, performance, or achievements will likely differ from the anticipated results, performance or achievements that are expressed or implied by our forward-looking statements, and such difference might be significant and harmful to our stockholders' interest. Many important factors that could cause such a difference are described under the caption "Risk Factors," in Item 1A of our Annual Report on Form 10-K for the most recent fiscal year ended April 30, which you should review carefully, and in our subsequent quarterly reports on Form 10-Q and current reports on Form 8-K. These reports are available on our investor relations website at www.kewaunee.com and on the SEC website at www.sec.gov. These forward-looking statements speak only as of the date of this document. The Company assumes no obligation, and expressly disclaims any obligation, to update any forward-looking statements, whether as a result of new information, future events or otherwise.
Contact: | Donald T. Gardner III |
704/871-3274 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/kewaunee-scientific-corporation-appoints-jorge-santos-as-vice-president-of-international-sales-laboratory-products-group-302742110.html
SOURCE Kewaunee Scientific Corporation